Nilotinib-induced metabolic dysfunction: insights from a translational study using in vitro adipocyte models and patient cohorts. (2019)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-018-0337-0
PubMed Identifier: 30692595
Publication URI: http://europepmc.org/abstract/MED/30692595
Type: Journal Article/Review
Volume: 33
Parent Publication: Leukemia
Issue: 7
ISSN: 0887-6924